Titel

Merkliste
1 Ergebnisse

Chimeric Antigens Receptor T Cell Therapy Improve the Progn..:

Guan-hua Hu ; Yi-fei Cheng ; Ying-xi Zuo...
https://www.frontiersin.org/articles/10.3389/fimmu.2021.731435/full. , 2022

Link: https://doi.org/10.3389/fimmu.2021.731435

RT Journal
T1 <Title>Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete Remission</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:af3c56d9f626408f844f712ad374a2b1&Exemplar=1&LAN=DE
				
A1 Guan-hua Hu
A1 Yi-fei Cheng
A1 Ying-xi Zuo
A1 Ying-jun Chang
A1 Pan Suo
A1 Jun Wu
A1 Yue-ping Jia
A1 Ai-dong Lu
A1 Ying-chun Li
A1 Yu Wang
A1 Shun-chang Jiao
A1 Long-ji Zhang
A1 Xiang-yu Zhao
A1 Chen-hua Yan
A1 Lan-ping Xu
A1 Xiao-hui Zhang
A1 Kai-yan Liu
A1 Le-ping Zhang
A1 Xiao-jun Huang
PB Frontiers Media S.A.
YR 2022
K1 measurable residual disease
K1 chimeric antigen receptor T-cell
K1 pre-empty therapy
K1 acute lymphocyte leukemia
K1 pediatrics
K1 Immunologic diseases. Allergy
K1 RC581-607
JF https://www.frontiersin.org/articles/10.3389/fimmu.2021.731435/full
LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2021.731435
DO https://doi.org/10.3389/fimmu.2021.731435
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)